I strongly agree. The makers of the treatment recoup their investment once the treatment goes into prod. But while in beta, it should be free to the patient.

I strongly agree. The makers of the treatment recoup their investment once the treatment goes into prod. But while in beta, it should be free to the patient. Without this rule, I can imagine a world where businesses make a living selling treatments that are never intended to get past the FDA's certificatuon process.